AGP Executive Report
Last update: 4 hours agoFDA & Biotech: Bayer won accelerated approval for HYRNUO (sevabertinib) as a first-line targeted therapy for HER2-mutated non-small cell lung cancer, based on strong response rates in a Phase I/II trial. Health Tech & Research: A New Jersey veterinarian submitted a urinary stone sample that marked the Minnesota Urolith Center’s 2 millionth analysis, highlighting progress in diagnosing and preventing pet urinary stones. Transit Tech: NJ Transit is rolling out free Wi‑Fi on buses (aiming for 83% by end of 2026), plus digital bus stop signage and improved arrival accuracy. Cybersecurity & Governance: A new report warns states that local governments often lack resources and authority to defend critical infrastructure, pushing states to step in despite uneven capabilities. Local Tech Policy: Newark’s council approved a temporary data-center moratorium to study impacts on electricity, water cooling, and neighborhood costs. Data & Fraud Prevention: New Jersey-based Sago launched SagoVerify to improve survey respondent quality by filtering low-quality and fraudulent participants before they enter research pipelines. Business & Hiring: Focus Crossroads (with NJ ties) acquired assets from Zintro to expand its expert-network and professional audience recruitment services. Education & AI: Kean University hit a fall enrollment milestone of about 23,000 students across its NJ and global campuses after its merger with New Jersey City University. Nuclear & Industry: Holtec Nuclear, headquartered in Camden, is pursuing a $900M U.S. IPO tied to growing data-center power demand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
